Browse

S-Space

Browsing by Author 2618

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 533

Issue Date Title / Author(s) / CitationFileAltmetrics
1998
A novel approach to glioma gene therapy: Down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes

Ke, L.D.; Fueyo, J.; Chen, X.; Steck, P.A.; Shi, Y.-X.; Im, S.-A.; Yung, W.K.A.

International Journal of Oncology, Vol.12 No.6, pp.1391-1396

DOI
1999-02
Antiangiogenesis treatment for gliomas: Transfer of antisense vascular endothelial growth factor inhibits tumor growth in vivo
1999-10
Distinct patterns of apoptosis in association with modulation of CD44 induced by thrombopoietin and granulocyte-colony stimulating factor during ex vivo expansion of human cord blood CD34(+) cells

Seoh, JY; Woo, SY; Im, SA; Kim, YJ; Park, HY; Lee, S; Lee, MA; Yoo, ES; Huh, JW; Ryu, KH; Lee, SN; Chung, WS; Seong, CM

British Journal of Haematology, Vol.107 No.1, pp.176-185

DOI
1999-10
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
DOI
2000
Mobilization kinetics of CD34(+) cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors
DOI
2000-04
Identification of ider(17q) in addition to t(15;17) in acute promyelocytic leukemia using whole chromosome painting probes made by interspecies hybrid using inter-alu PCR
DOI
2000-04
Identification of ider(17q) in addition to t(15;17) in acute promyelocytic leukemia using whole chromosome painting probes made by interspecies hybrid using inter-alu PCR
DOI
2000-06
The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines

Ke, L.D.; Shi, Y.-X.; Im, S.-A.; Chen, X.; Yung, W.K.A.

Clinical Cancer Research, Vol.6 No.6, pp.2562-2572

2001-05
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF

Im, SA; Kim, JS; Gomez-Manzano, C; Fueyo, J; Liu, TJ; Cho, MS; Seong, CM; Lee, SN; Hong, YK; Yung, WKA

British Journal of Cancer, Vol.84 No.9, pp.1252-1257

DOI
2001-05
Apoptosis and megakaryocytic differentiation during ex vivo expansion of human cord blood CD34(+) cells using thrombopoietin

Ryu, KH; Chun, S; Carbonierre, S; Im, Seock Ah; Kim, HL; Shin, MH; Shin, HY; Ahn, HS; Woo, SY; Seoh, JY; Fraser, JK

British Journal of Haematology, Vol.113 No.2, pp.470-478

DOI
2001-10
DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway

Wang, SC; Makino, K; Xia, WY; Kim, JS; Im, SA; Peng, H; Mok, SC; Singletary, SE; Hung, MC

Oncogene, Vol.20 No.47, pp.6960-6964

DOI
2002-01
Decrease in apoptosis and increase in polyploidization of megakaryocytes by stem cell factor during ex vivo expansion of human cord blood CD34(+) cells using thrombopoietin
DOI
2003-03
Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion
DOI
2003-04
In vitro differentiation of natural killer T cells from human cord blood CD34+ cells
DOI
2003-04
A Clinical Analysis of PTEN Expressions in Breast Cancers
2003-04
The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines
2003-05
A case of pyothorax-associated lymphoma simulating empyema necessitatis
DOI
2003-06
Gemcitabine and Infusional 5-Fluorouracil in Advanced Pancreatic Cancer: A Clinical Benefit Response-Oriented Phase II Study
2003-08
Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: Multicenter trial
DOI
2003-08
Challenging problems in advanced malignancy - Case 1. Chylopericardium during the treatment of non-Hodgkin's lymphoma
DOI
2003-12
적혈구, 혈소판 및 신선동결혈장 수혈의 적정성 평가

김윤희; 정은선; 임석아; 정락경; 김승철; 이미애; 정화순

Annals of Laboratory Medicine, Vol.23 No.6, pp.448-454

2004-04
직장출혈력이 없는 빈혈 환자에서의 대장내시경의 역할

강인숙; 정성애; 임석아; 김성은; 심기남; 유권; 문일환

Clinical Endoscopy, Vol.28 No.4, pp.173-178

2004-08
First-line chemotherapy with irinotecan plus capecitabine for advanced colorectal cancer

Park, SH; Bang, SM; Cho, EK; Baek, JH; Oh, JH; Im, SA; Park, YS; Shin, DB; Lee, JH

Oncology, Vol.66 No.5, pp.353-357

DOI
2004-11
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004-12
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
DOI
2005-01
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
DOI
2005-04
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005-06
Cytotoxic effects of pemetrexed in gastric cancer cells
DOI
2005-06
The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma
2005-08
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor
DOI
2005-08
A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer

Cho, EK; Lee, WK; Im, SA; Lee, SN; Park, SH; Bang, SM; Park, DK; Park, YH; Shin, DB; Lee, JH

Oncology, Vol.68 No.4-6, pp.333-340

DOI
2005-09
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
DOI
2005-10
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
view fileDOI
2005-11
Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas
DOI
2005-12
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
DOI
2005-12
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
DOI
2006-02
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
DOI
2006-03
Antibiotic use during the last days of life in cancer patients

Oh, D. Y.; Kim, J. H.; Kim, D. W.; Im, S. A.; Kim, T. Y.; Heo, D. S.; Bang, Y. J.; Kim, N. K.

European Journal of Cancer Care, Vol.15 No.1, pp.74-79

DOI
2006-04
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006-06
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
DOI
2006-07
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
DOI
2006-07
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
DOI
2006-08
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view fileDOI
2006-09
Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells
2006-11
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007-04
Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression

Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Kim, Hwang-Phill; Park, Jung-Hyun; Jung, Yeonjoo; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You

Biochemical and Biophysical Research Communications, Vol.355 No.2, pp.318-323

DOI
2007-04
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007-05
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
DOI
2007-06
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal
DOI
2007-09
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view file
2007-10
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy
DOI
2007-11
Negative impact of heat exposure on cosmesis after conservative treatment for breast cancer
DOI
2007-11
Discrepancies in performance status scores as determined by cancer patients and oncologists: are they influenced by depression?

Jeon, Hong Jin; Shim, Eun-Jung; Shin, Yong-Wook; Oh, Do-Youn; Im, Seock-Ah; Heo, Dae Seog; Hahm, Bong-Jin

General Hospital Psychiatry, Vol.29 No.6, pp.555-561

DOI
2007-11
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view fileDOI
2008
Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells

Choi, Moon-Chang; Lee, Yang-Ui; Kim, Sung-Hak; Lee, Ju-Hee; Park, Jung-Hyun; Streb, Jeffrey W.; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Jong, Hyun-Soon; Bang, Yung-Jue

International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2534-2543

DOI
2008
DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription

Kim, Sung-Hak; Park, Jinah; Choi, Moon-Chang; Park, Jung-Hyun; Kim, Hwang-Phill; Lee, Ju-Hee; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Tae-You

International Journal of Biochemistry and Cell Biology, Vol.40 No.11, pp.2462-2471

DOI
2008-01
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
DOI
2008-01
Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin
DOI
2008-02
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008-03
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
DOI
1 2 3 4 5 69

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr youtube

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library LOGIN